Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John F. Paolini currently holds 61,324 shares of Kiniksa Pharmaceuticals, Ltd. (KNSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John F. Paolini has been a net seller of KNSA stock. They have purchased $0 and sold $9.1M worth of shares.
John F. Paolini's most recent insider trade was on Oct 31, 2025, when they sold 82,542 shares at $37.14 per share.
John F. Paolini serves as Executive at Kiniksa Pharmaceuticals, Ltd. (KNSA). They have executed 88 insider transactions totaling $9.1M over their tenure at the company.
John F. Paolini holds the position of Executive at Kiniksa Pharmaceuticals, Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
John F. Paolini has shown a selling trading pattern, with $0 in total purchases and $9.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John F. Paolini was on Oct 31, 2025, when they sold $3.1M worth of KNSA shares. This transaction involved 82,542 shares at $37.14 per share.
John F. Paolini currently owns 61,324 shares of Kiniksa Pharmaceuticals, Ltd. (KNSA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John F. Paolini's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John F. Paolini has 88 Form 4 filings on record as an insider at Kiniksa Pharmaceuticals, Ltd..
Set alerts for John F. Paolini and 40,000+ other insiders.